Fetal growth trajectories in Type-1 diabetic pregnancy

E J H Mulder1, C M Koopman, J K Vermunt

  • 1Department of Perinatology and Gynecology, University Medical Centre, Utrecht, The Netherlands. emulder@umcutrecht.nl

Insights

Fetal growth patterns in Type-1 diabetic pregnancies are established early. Maternal glycemic control significantly influences fetal overgrowth (macrosomia) and birth weight, especially before 12 weeks gestation.

Area of Science:

  • Perinatology
  • Maternal-Fetal Medicine
  • Endocrinology

Background:

  • Intrauterine growth patterns vary significantly among fetuses of women with Type-1 diabetes.
  • Identifying determinants of fetal overgrowth (macrosomia) is crucial for optimizing pregnancy outcomes.

Purpose of the Study:

  • To characterize individual fetal growth trajectories in Type-1 diabetic pregnancies.
  • To investigate factors influencing fetal overgrowth and its timing.

Main Methods:

  • Retrospective longitudinal study of 76 singleton Type-1 diabetic pregnancies.
  • Latent class analysis to identify distinct fetal abdominal circumference (AC) growth patterns.
  • Analysis of maternal factors, including HbA1c, related to fetal growth.

Main Results:

  • Four distinct fetal AC growth patterns were identified.
  • Early acceleration of AC growth (before 25 weeks) strongly predicted macrosomia.
  • Poor glycemic control (HbA1c > 7.0%) before 12 weeks gestation modestly predicted midtrimester AC growth.

Conclusions:

  • Fetal growth trajectories are established early in gestation.
  • Maternal glycemic status during early pregnancy is a key determinant of fetal growth and birth weight in Type-1 diabetes.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...